Ancoclician announced the opening of the unit in Riyadh, Saudi Arabia
A. AnkoklinicThe reference in cancer treatments declares the expansion of its operations to the international scenario. The company is about to launch its first unit outside Brazil, which is in Riyadh Saudi Arabia.
CEO Bruno Ferrari of Oncolonicas revealed in an interview CNN Operations in the new unit will begin on August 1. Expansion represents an important step in the company’s global growth strategy.
Described as the new unit A in Riyadh Premium InstallationOccupy an area of 12,800 square meters. Ferrari believes that the center offers full -scale cancer services, including radiotherapy, various types of infusion, chemotherapy and immunotherapy.
In addition to the treatment, the unit also provides comprehensive analysis services to cancer patients. The inclusion of a clinic in the prevention of cancer prevents additional differential, the commitment of Oncoklinicas strengthens perfect health care.
The unit inauguration in Saudi Arabia not only represents the geographical enlargement of Ankoklinicas, but also the opportunity to share sophisticated oncology expertise and technologies with the new market.
This strategic movement keeps the company a global player in the field of health, especially oncology.
Experts: Brazil can lead to a transition to a lower carbon market
